Artificial Pancreas Device System Market Intelligence Report Covers Trends, Segments And Regional Growth

The artificial pancreas device system market is on the cusp of significant expansion, driven by technological advances and a growing emphasis on improving diabetes management. With innovations that promise greater automation and personalized care, this market is set to transform how patients regulate blood glucose levels, making treatment less burdensome and more effective.

Projected Market Value and Growth Dynamics of the Artificial Pancreas Device System Market
The market for artificial pancreas device systems is forecasted to grow swiftly, reaching a valuation of $3.92 billion by 2030. This growth corresponds to a robust compound annual growth rate (CAGR) of 13.7%. The primary factors accelerating this rise include heightened demand for fully automated glucose control, increased investments in digital solutions for diabetes, broader adoption of remote patient monitoring, a stronger focus on tailored insulin therapies, and growing regulatory support for advanced diabetes devices. Key trends expected to shape the market include wider acceptance of closed-loop glucose control systems, deeper integration of continuous glucose monitoring (CGM) with insulin pumps, the use of predictive algorithms for insulin delivery, expansion in wearable diabetes management technologies, and an intensified focus on patient-centered automation.

The artificial pancreas device system market size has grown rapidly in recent years. It will grow from $2.06 billion in 2025 to $2.35 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to increasing prevalence of diabetes, early adoption of insulin pump technologies, expansion of continuous glucose monitoring usage, improvements in medical sensor accuracy, growing awareness of automated diabetes management.

Download a free sample of the artificial pancreas device system market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Companies Leading the Artificial Pancreas Device System Industry
Several prominent players dominate the artificial pancreas device system landscape, including Medtronic plc, Abbott Laboratories, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Roche Diabetes Care, Ypsomed, SOOIL Development, Beta Bionics Inc., Bigfoot Biomedical Inc., Diabeloop SA, Inreda Diabetic B.V., Defymed SAS, DreaMed Diabetes Ltd., Medtrum Technologies Inc., EOFlow Co. Ltd., Cellnovo, Pancreum Inc., Admetsys Corporation, GlucoModicum, and MicroTech Medical.
A notable development occurred in September 2023 when Abbott Laboratories, a US-based pharmaceutical giant, acquired Bigfoot Biomedical for an undisclosed sum. This move strengthened Abbott's position in the diabetes care market by enhancing its portfolio centered on the Freestyle Libre continuous glucose monitoring system. The acquisition also aligns with Abbott's goal of developing integrated solutions that offer more personalized and precise diabetes management. Bigfoot Biomedical specializes in creating prototypes of automated insulin delivery devices, also known as artificial pancreas systems.

Emerging Trends Highlighted Within the Artificial Pancreas Device System Market
Industry leaders are focusing on developing automated insulin delivery systems that aim to mimic the natural function of a healthy pancreas. These systems continuously monitor blood glucose and deliver insulin automatically, reducing the need for manual intervention and constant monitoring for diabetes patients.
For example, in May 2023, Beta Bionics, a US medical device manufacturer, secured FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System. This innovative artificial pancreas system autonomously calculates and administers insulin doses based on glucose readings from a connected continuous glucose monitor. It operates as a closed-loop system, adjusting insulin delivery in real time by using only the user's body weight and an estimate of meal size, making diabetes management more streamlined and responsive.

View the full artificial pancreas device system market report:
https://www.thebusinessresearchcompany.com/report/artificial-pancreas-device-system-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Breakdown of Key Segments in the Artificial Pancreas Device System Market Report
The artificial pancreas device system market is divided into the following segments:
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Further subcategories include:
- Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
- Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
- Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems

This detailed segmentation helps provide clarity on the diverse technologies, treatment approaches, and user types driving the artificial pancreas device system market forward.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.